Orchid Pharma vs Nifty 50: Returns Compared

Orchid Pharma vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Orchid Pharma trades on the NSE under the symbol ORCHPHARMA, and its 1-month return of -4.26% compares with -5.12% for the Nifty 50 over the same period.

The Orchid Pharma vs Nifty 50 comparison matters because Orchid Pharma is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Orchid Pharma share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 8 October 2026.

Also read – Omax Autos vs Nifty 50: Returns Compared

Click Here – Get Free Investment Predictions

Orchid Pharma vs Nifty 50: Performance at a Glance

The table below sets out the Orchid Pharma vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 8 October 2026.

Time Frame	Orchid Pharma Return	Nifty 50 Return	Difference
1 Month	-4.26%	-5.12%	+0.86 pp
3 Months	-6.64%	-7.22%	+0.58 pp
6 Months	+81.08%	-6.49%	+87.57 pp
1 Year	+32.39%	-11.71%	+44.10 pp
3 Years	+93.21%	+13.94%	+79.27 pp

On the Orchid Pharma vs Nifty 50 scorecard, Orchid Pharma has beaten the index over the latest 1-year window, returning +32.39% against -11.71% for the Nifty 50, a difference of 44.10 percentage points. The widest gap on the table is over six months, where Orchid Pharma gained 81.08% while the Nifty 50 fell 6.49%, a difference of 87.57 percentage points in favour of the stock. The direction differs over the past year: Orchid Pharma moved up while the Nifty 50 moved down.

Check the Univest Screener for live Orchid Pharma and Nifty 50 data

Latest Close and 52-Week Range: Orchid Pharma and the Nifty 50

Instrument	Latest Close	52-Week High	52-Week Low	Vs 52-Week High
Orchid Pharma	Rs 981.20	Rs 1,143.50	Rs 480.00	-14.2%
Nifty 50	22,231.80	26,373.20	22,179.90	-15.7%

Orchid Pharma closed at Rs 981.20 on 8 October 2026, which is 14.2% below its 52-week high of Rs 1,143.50 and 104.4% above its 52-week low of Rs 480.00. The Nifty 50 closed at 22,231.80, 15.7% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Orchid Pharma vs Nifty 50 Gap Exists

Orchid Pharma can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Orchid Pharma has traded between Rs 480.00 and Rs 1,143.50, a spread of 138.2% from low to high, against 18.9% for the Nifty 50.

Trading depth also shapes the Orchid Pharma vs Nifty 50 gap. Stocks with a smaller trading base tend to react more to a single result, block deal or news item than the diversified Nifty 50 does, and Orchid Pharma is judged on its own record rather than on an average.

Download the Univest iOS App or Univest Android App to track Orchid Pharma and Nifty 50 live on the go.

Orchid Pharma vs Nifty 50: Has Orchid Pharma Beaten the Benchmark?

Yes, over the past year. Orchid Pharma returned +32.39% against -11.71% for the Nifty 50, a lead of 44.10 percentage points. Across all five time frames measured, Orchid Pharma is ahead of the index.

Risks of the Orchid Pharma vs Nifty 50 Comparison

Point-to-point returns can mislead, and the Orchid Pharma vs Nifty 50 comparison is no exception. A different start date would shift every figure in the table above, and past performance does not indicate how either Orchid Pharma or the Nifty 50 will perform from here.

Also read – Orient Bell vs Nifty 50: Returns Compared

Orchid Pharma carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 480.00 to Rs 1,143.50 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Orchid Pharma vs Nifty 50 currently reads in the stock's favour on every time frame measured, led by the six months window. Even so, a single stock's record can reverse quickly, so investors should weigh Orchid Pharma's volatility, liquidity and sector concentration alongside its returns and consult a SEBI-registered advisor before making an allocation decision.

Has Orchid Pharma outperformed the Nifty 50 in the last year?

Ans. Yes. Orchid Pharma returned +32.39% over the past year while the Nifty 50 returned -11.71%, based on NSE closing prices to 8 October 2026.

How does Orchid Pharma vs Nifty 50 look over 3 years?

Ans. Over three years Orchid Pharma has returned +93.21% compared with the Nifty 50's +13.94%, so in the Orchid Pharma vs Nifty 50 comparison the stock has been ahead over this horizon.

What is the Orchid Pharma share price today compared to Nifty 50?

Ans. Orchid Pharma share price closed at Rs 981.20 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.

What is the 52-week high and low of Orchid Pharma?

Ans. Orchid Pharma's 52-week high is Rs 1,143.50 and its 52-week low is Rs 480.00, based on NSE data. The latest close of Rs 981.20 is 14.2% below the high.

Why does Orchid Pharma show bigger price swings than the Nifty 50?

Ans. Orchid Pharma carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Orchid Pharma has traded in a 138.2% low-to-high range against 18.9% for the index, a key reason the Orchid Pharma vs Nifty 50 return gap varies across time frames.

Is Orchid Pharma a good long-term investment compared to a Nifty 50 index fund?

Ans. Orchid Pharma's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Orchid Pharma vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.